Yeast-based therapeutic for chronic hepatitis B virus infection

Yeast-based therapeutic for chronic hepatitis B virus infection

  • CN 103,476,426 B
  • Filed: 02/09/2012
  • Issued: 08/10/2021
  • Est. Priority Date: 02/12/2011
  • Status: Active Grant
First Claim
Patent Images

1. An immunotherapeutic composition comprising:

  • a) whole yeast from the genus Saccharomyces (Saccharomyces); and

    b) a fusion protein comprising a plurality of HBV antigens, wherein the plurality of HBV antigens consists of the amino acid sequence of SEQ ID NO;

    130 or SEQ ID NO;

    150,the compositions elicit HBV-specific immune responses.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×